XML 63 R41.htm IDEA: XBRL DOCUMENT
v3.24.3

Earnings per Share (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Earnings Per Share [Abstract] |
Basic and diluted earnings per share | Basic and diluted shares outstanding used in our earnings per share calculation are calculated as follows:
|  | For the Three Months Ended September 30, |  | For the Nine Months Ended September 30,
(In millions) |  | 2024 |  | 2023 |  | 2024 |  | 2023
Numerator: |  |  |  |  |  |  |  |
Net income (loss) attributable to Biogen Inc. |  | $ | 388.5 |  |  | $ | (68.1) |  |  | $ | 1,365.5 |  |  | $ | 911.4 |
Denominator: |  |  |  |  |  |  |  |
Weighted average number of common shares outstanding |  | 145.7 |  |  | 144.8 |  |  | 145.5 |  |  | 144.7 |
Effect of dilutive securities: |  |  |  |  |  |  |  |
Time-vested restricted stock units |  | 0.3 |  |  | — |  |  | 0.4 |  |  | 0.7 |
Performance stock units settled in stock |  | 0.1 |  |  | — |  |  | 0.1 |  |  | 0.1 |
Dilutive potential common shares |  | 0.4 |  |  | — |  |  | 0.5 |  |  | 0.8 |
Shares used in calculating diluted earnings per share |  | 146.1 |  |  | 144.8 |  |  | 146.0 |  |  | 145.5 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration